Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Beer

Showing results (681-690 of 888) with videos related to

Pageof 89
Sort By:
Cancer|February 10, 2010
Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancerMark Garzotto, Celestia S Higano, Catherine O'Brien, et al.
Anti-Cancer Drugs|September 27, 2016
Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlatesColin P Bergstrom, Brian Ruffell, Christine M T Ho, et al.
Journal of Medicinal Chemistry|March 20, 1992
Novel 5-HT3 antagonists: indol-3-ylspiro(azabicycloalkane-3,5'(4'H)-oxazoles)C J Swain, R Baker, C Kneen, et al.
The Journal of Urology|January 13, 2006
Testosterone loss and estradiol administration modify memory in menTomasz M Beer, Lisa B Bland, Joseph R Bussiere, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 6, 2021
Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise?Kerri M Winters-Stone, Cassie Boisvert, Fuzhong Li, et al.
Radiology|September 25, 2001
Assessment of myocardial infarction in humans with (23)Na MR imaging: comparison with cine MR imaging and delayed contrast enhancementJ J Sandstede, T Pabst, M Beer, et al.
JAMA Network Open|June 15, 2021
Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical TrialAntonio Finelli, Tomasz M Beer, Simon Chowdhury, et al.
BMC Cardiovascular Disorders|October 30, 2016
Myocardial lipid content in Fabry disease: a combined <sup>1</sup>H-MR spectroscopy and MR imaging study at 3 TeslaB Petritsch, H Köstler, A M Weng, et al.
Insights Into Imaging|June 15, 2012
MRI of the lung (3/3)-current applications and future perspectivesJürgen Biederer, S Mirsadraee, M Beer, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 16, 2012
Non-invasive determination of myocardial lipid content in Fabry disease by 1H-MR spectroscopyB Petritsch, H Köstler, W Machann, et al.
Pageof 89

Showing results (681-690 of 888) with videos related to

Sort By:
Pageof 89
Cancer|February 10, 2010
Phase 1/2 study of preoperative docetaxel and mitoxantrone for high-risk prostate cancerMark Garzotto, Celestia S Higano, Catherine O'Brien, et al.
Anti-Cancer Drugs|September 27, 2016
Docetaxel and mitoxantrone before radical prostatectomy in men with high-risk prostate cancer: 10-year follow-up and immune correlatesColin P Bergstrom, Brian Ruffell, Christine M T Ho, et al.
Journal of Medicinal Chemistry|March 20, 1992
Novel 5-HT3 antagonists: indol-3-ylspiro(azabicycloalkane-3,5'(4'H)-oxazoles)C J Swain, R Baker, C Kneen, et al.
The Journal of Urology|January 13, 2006
Testosterone loss and estradiol administration modify memory in menTomasz M Beer, Lisa B Bland, Joseph R Bussiere, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 6, 2021
Delivering exercise medicine to cancer survivors: has COVID-19 shifted the landscape for how and who can be reached with supervised group exercise?Kerri M Winters-Stone, Cassie Boisvert, Fuzhong Li, et al.
Radiology|September 25, 2001
Assessment of myocardial infarction in humans with (23)Na MR imaging: comparison with cine MR imaging and delayed contrast enhancementJ J Sandstede, T Pabst, M Beer, et al.
JAMA Network Open|June 15, 2021
Comparison of Joint and Landmark Modeling for Predicting Cancer Progression in Men With Castration-Resistant Prostate Cancer: A Secondary Post Hoc Analysis of the PREVAIL Randomized Clinical TrialAntonio Finelli, Tomasz M Beer, Simon Chowdhury, et al.
BMC Cardiovascular Disorders|October 30, 2016
Myocardial lipid content in Fabry disease: a combined <sup>1</sup>H-MR spectroscopy and MR imaging study at 3 TeslaB Petritsch, H Köstler, A M Weng, et al.
Insights Into Imaging|June 15, 2012
MRI of the lung (3/3)-current applications and future perspectivesJürgen Biederer, S Mirsadraee, M Beer, et al.
Rofo : Fortschritte Auf Dem Gebiete Der Rontgenstrahlen Und Der Nuklearmedizin|August 16, 2012
Non-invasive determination of myocardial lipid content in Fabry disease by 1H-MR spectroscopyB Petritsch, H Köstler, W Machann, et al.
Pageof 89